Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Cell Cycle Control System01:28

The Cell Cycle Control System

6.4K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
6.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
3.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

4.1K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variants associated mRNA stability in lung.

BMC genomics·2022
Same author

Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer.

PLoS computational biology·2022
Same author

Comparison of the diagnostic efficacy of <sup>68</sup> Ga-FAPI-04 PET/MR and <sup>18</sup>F-FDG PET/CT in patients with pancreatic cancer.

European journal of nuclear medicine and molecular imaging·2022
Same author

Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.

American journal of epidemiology·2022
Same author

68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in a Case of Peutz-Jeghers Syndrome.

Clinical nuclear medicine·2022
Same author

Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells.

Journal of diabetes and its complications·2022
Same journal

ERG orchestrates a dedifferentiation-senescence-inflammation triad in prostate cancer.

Molecular cancer research : MCR·2026
Same journal

Comprehensive multi-omic profiling of desmoplastic small round cell tumors identifies targetable pathways with therapeutic opportunities.

Molecular cancer research : MCR·2026
Same journal

CELF2 is a tumor suppressor that modulates SLC7A11 and promotes ferroptosis in stomach adenocarcinoma.

Molecular cancer research : MCR·2026
Same journal

MYC-Mediated USP39 Upregulation Stabilizes SRSF1 in Pancreatic Cancer.

Molecular cancer research : MCR·2026
Same journal

Ceramide-induced endoplasmic reticulum stress reveals a targetable vulnerability in endocrine therapy-resistant breast cancer.

Molecular cancer research : MCR·2026
Same journal

Mapping the Subtype-Specific PARP1 ADP-ribosylated Proteome in Breast Cancer Cells.

Molecular cancer research : MCR·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K

Integrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic Value.

Chao Cheng1, Shaoke Lou2, Erik H Andrews2

  • 1Department of Genetics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. Institute for Quantitative Biomedical Sciences, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire. Chao.Cheng@dartmouth.edu.

Molecular Cancer Research : MCR
|February 10, 2016
PubMed
Summary
This summary is machine-generated.

This study identifies key gene regulatory programs in liposarcoma subtypes, revealing E2F1 and E2F4 activity as prognostic markers for patient survival. These findings offer insights into liposarcoma mechanisms and prognosis prediction.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.6K

Related Experiment Videos

Last Updated: Mar 26, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

28.7K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K
Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Liposarcoma, the second most common sarcoma, has distinct molecular subtypes impacting patient prognosis.
  • Transcriptional regulatory programs in liposarcoma subtypes remain largely uninvestigated.

Purpose of the Study:

  • To systematically define transcriptional regulatory programs in liposarcoma.
  • To identify subtype-specific and prognostic regulatory programs using computational methods.

Main Methods:

  • Integrative analysis of gene expression profiles, ChIP-Seq data, curated gene sets, and clinical information.
  • Computational identification of regulatory programs and prognostic gene signatures.

Main Results:

  • Discrete regulatory programs, notably those controlled by E2F1 and E2F4, show differential activity across liposarcoma subtypes compared to normal adipose tissue.
  • Higher activity of E2F4 or E2F1 is associated with unfavorable prognosis in liposarcoma patients.
  • 259 gene sets significantly correlate with patient survival, with over 50% linked to cell cycle and proliferation.

Conclusions:

  • Integrative analyses reveal distinct, prognostic regulatory programs in liposarcoma.
  • The identified framework can be applied to understand mechanisms and predict prognosis in various cancer types.